Last reviewed · How we verify
Control/Placebo group
A control or placebo group receives no active intervention and serves as a comparator to measure the efficacy and safety of an investigational drug.
At a glance
| Generic name | Control/Placebo group |
|---|---|
| Sponsor | University of Virginia |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
In clinical trials, a placebo or control group is administered an inactive substance or standard-of-care treatment to establish a baseline for comparison. This allows researchers to isolate the true effect of the investigational drug by accounting for natural disease progression, regression to the mean, and the placebo effect.
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 and MAS825 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Clonal Hematopoiesis of Indeterminate Potential (CHIP) (PHASE2)
- A Clinical Trial Evaluating the Monkeypox Recombinant Protein Vaccine (PHASE1)
- Effects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy (NA)
- Project Tendura: The Impact of Blood Flow Restriction Resistance Training (BFR-RT) in Patients With Achilles Tendon Rupture (ATR) Repair (NA)
- Effect of Kinesio Taping Application in Addition to Pilates Exercises on Core Muscle Thickness, Cognition and Mental Fatigue in Individuals With Non-specific Low Back Pain (NA)
- The RECLAIM Study. (NA)
- Effects of Positive Psychological Group Psychotherapy and Auricular Acupressure on Withdrawal Symptoms (NA)
- USC-Exos in Corpus Spongiosum Reconstruction for Hypospadias (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Control/Placebo group CI brief — competitive landscape report
- Control/Placebo group updates RSS · CI watch RSS
- University of Virginia portfolio CI